NCT00375258View on ClinicalTrials.gov

Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage

PHASE3CompletedINTERVENTIONAL
Enrollment

20,211

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions
Hemorrhage
Interventions
DRUG

Tranexamic acid

Loading dose of 1 gram then 1 gram by infusion over 8 hours

DRUG

Sodium Chloride 0.9%

Visual matched placebo

Trial Locations (1)

Unknown

Over 50 countries Worldwide, London

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00375258 - Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage | Biotech Hunter | Biotech Hunter